“COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities”, J. Can. Res. Updates, vol. 5, no. 2, pp.  45–46, Mar. 2016, doi: 10.6000/1929-2279.2016.05.02.1.